Literature DB >> 27999653

Erythema nodosum: what should we consider about it?

Farhang Babamahmoudi1, Arghavan Amuzgar1, Tahoora Mousavi2, Lotfollah Davoodi1.   

Abstract

Entities:  

Keywords:  Erythema nodosum; Erythematous; Panniculitis

Year:  2016        PMID: 27999653      PMCID: PMC5153527     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


× No keyword cloud information.
Dear Editor, Erythema nodosum (EN) or panniculitis is a cutaneous reaction consisting of inflammatory tender erythematous nodular lesions, spontaneously regressing located primarily over the extensor surface of lower extremities (1). EN can occur at any age but its peak incidence is between the third and fourth decades (2). Prevalence of EN is 3-5 times higher in women than men (3). Erythema nodosum is panniculitis and associated with variety of conditions such as: infectious disease(4), drugs (5), pregnancy (6), autoimmune disease (7), idiopathic (8). This study was carried out at the Central Infectious unit of a university hospital (Quaemshahr Razi) between 2012 to 2015. In 53 probable cases, 21 patients were confirmed cases with biopsy samples, and the others were excluded from the study. Their ages was above 14 years old comprising 5 males and 16 females (sex ratio 3.2/1). The evaluation began by taking physical examination, family history and drug history and underlying conditions. The patient underwent a complete laboratory. In our finding, all patients, skin biopsy sample that showed panniculitis were taken. Table 1 shows the probable underlying disease. In this study, in one female patient, all her four extremities had EN while in 2 females, their three extremities (bilateral upper extremities with on lower limb) were affected. In patients, the rise of LFT tests (liver function tests AST and ALT) and rise of renal function tests (blood urea and creatinin) were not detected.
Table 1

The probable underlying disease

Etiology Female 16(76%), 16-76 years Male 5(24%), 12-76 years Total
Brucellosis 3(14%)1(20%)4(19.4%)
Granulomatos mastitis2(12.5%)0(0%)2(9.52%)
Oral contraceptives3(14%)0(0%)3(14.28%)
EN in pregnancy 2(12.5%)0(0%)2(9.52%)
Sarcoidosis0(0%)1(20%)1(4.76%)
IBD(ulcerative colitis)1(6.25%)0(0%)1(4.76%)
Atypical pneumonia2(12.5%)0(0%)2(9.52%)
Cellulitis0(0%)1(20%)1(4.76%)
Streptococcal pharyngitis 1(6.25%)0(0%)1(4.76%)
Idiopathic2 (12.5%)2(40%)4(19.4%)
Bilateral leg EN 7(43.75%)4(80%)11(52%)
Unilateral leg EN5(31.25%)2(40%)7(33%)
Increase ESR13(81.25%)3(60%)16(76%)
Increase CRP8(50%)4(80%)12(57%)
Increase ESR and CRP6(37.5)2(40%)8(38%)
Increase wright , 2ME , coombs wright3(14%)1(20%)4(19.4%)
Increase WBC count2(12.5%)1(20%)3(14%)
Atypical pneumonia2(12.5%)0(0%)2(9.52%)
Rise of ASO (anti streptolyzin)1(6.25%)0(0%)1(4.76%)
Increase ACE level (angiotensin converting enzyme)0(0%)1(20%)1(4.76%)
Sum16521
In a prospective study that was carried out at the University Hospital of Ioannina, almost all (98%) patient had EN over the extensor surface of lower extremities, mainly on the shins and bilaterally in 82%. Our finding was different as described above (6). In one finding in Strasburg, data confirmed the predominance of streptococcal infections and sarcoidosis among patients with EN. Tuberculosis virtually disappeared, since the last case was observed in 1962. Various viral or bacterial disease are performed to determine the true prevalence of EN related diseases (9). Another study in Verona, Italy showed that in 58.8% patients, an etiology of the first manifestation of EN was attributed to infections (25.8% of total number; 32% of those with an attributed etiology), drugs(mostly sex hormones; 15.35%; 26%), systemic disease (11.2%;19.2%) and pregnancy (6.5%; 10.9%). EN relapsed in 33 (26.6%) patients and was mostly attributed to infections and drugs. Factors responsible for the first manifestation of EN frequently differed from those causing relapses in the same patients, with the exception of drug-induced EN. In this study, we conclude that drug-induced EN can recur after re-exposure to the same drug, and the recurrence can be predicted (10). The probable underlying disease In this investigation, the underlying etiology that we found was different from other studies, probably due to epidemiologic differences in each region. Thus, we suggest physicians consider endemic disease, such as brucellosis in patients with E.N to avoid misdiagnosing. General lab data consisting CBC, electrolities, LFT, etc. did not have diagnostic role in our study and each patient was only diagnosed when we tested a specific etiology (Wright, ACE, ASO, etc). Although, we should not forget that the first key is the complete history taking and physical examination.
  11 in total

1.  Erythema nodosum: etiological factors and relapses in a retrospective cohort study.

Authors:  Anastasia Papagrigoraki; Paolo Gisondi; Paolo Rosina; Manuela Cannone; Giampiero Girolomoni
Journal:  Eur J Dermatol       Date:  2010-10-28       Impact factor: 3.328

2.  Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study.

Authors:  Sinéad M Langan; Richard W Groves; Tim R Card; Martin C Gulliford
Journal:  J Invest Dermatol       Date:  2012-04-26       Impact factor: 8.551

3.  Erythema nodosum: an evaluation of 100 cases.

Authors:  A Mert; H Kumbasar; R Ozaras; S Erten; L Tasli; F Tabak; R Ozturk
Journal:  Clin Exp Rheumatol       Date:  2007 Jul-Aug       Impact factor: 4.473

4.  Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort.

Authors:  Kristian Tore Jørgensen; Bo Vestergaard Pedersen; Nete Munk Nielsen; Søren Jacobsen; Morten Frisch
Journal:  J Autoimmun       Date:  2011-08-02       Impact factor: 7.094

Review 5.  Erythema nodosum: a sign of systemic disease.

Authors:  Robert A Schwartz; Stephen J Nervi
Journal:  Am Fam Physician       Date:  2007-03-01       Impact factor: 3.292

Review 6.  Cutaneous sarcoidosis: a dermatologic masquerader.

Authors:  Rajani Katta
Journal:  Am Fam Physician       Date:  2002-04-15       Impact factor: 3.292

Review 7.  Etiology and therapeutic management of erythema nodosum during pregnancy: an update.

Authors:  K Alexandra Acosta; Mary Claire Haver; Brent Kelly
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

8.  Erythema nodosum in children: a prospective study.

Authors:  T Kakourou; P Drosatou; F Psychou; K Aroni; P Nicolaidou
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

9.  Erythema nodosum and associated diseases. A study of 129 cases.

Authors:  B Cribier; A Caille; E Heid; E Grosshans
Journal:  Int J Dermatol       Date:  1998-09       Impact factor: 2.736

10.  Idiopathic granulomatous mastitis with erythema nodosum simulating breast abscess in pregnancy: A case report.

Authors:  Romeo Lucas; Debra Gussman; Rachael L Polis; Meghan I Rattigan; Theodore J Matulewicz
Journal:  Obstet Med       Date:  2013-10-30
View more
  4 in total

Review 1.  Erythema nodosum.

Authors:  Alexander K C Leung; Kin Fon Leong; Joseph M Lam
Journal:  World J Pediatr       Date:  2018-09-29       Impact factor: 2.764

Review 2.  Erythema Nodosum: A Practical Approach and Diagnostic Algorithm.

Authors:  Daniela Michelle Pérez-Garza; Sonia Chavez-Alvarez; Jorge Ocampo-Candiani; Minerva Gomez-Flores
Journal:  Am J Clin Dermatol       Date:  2021-03-08       Impact factor: 7.403

3.  Tuberculosis-Associated Erythema Nodosum.

Authors:  Jennifer Laborada; Philip R Cohen
Journal:  Cureus       Date:  2021-12-05

4.  Clinicopathological Characteristics Related to Etiologies of Erythema Nodosum: A 10-Year Retrospective Study.

Authors:  Preeyachat Limtong; Poonkiat Suchonwanit; Kumutnart Chanprapaph; Suthinee Rutnin
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.